4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-002260
Chief Financial Officer sold 47,195 shares at $45.14 ($2,130,382)
- Chief Financial Officer acquired 39,886 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrell Terry-Ann Chief Financial Officer | 2023-01-18 | Option exercise | +39,886 | $13.68 | $545,640 | 78,472 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-01-18 | Sale | −47,195 | $45.14 | $2,130,382 | 31,277 | D |
| Derivatives | |||||||
| Burrell Terry-Ann Chief Financial Officer | 2023-01-18 | Option exercise · Stock Option (Right to Buy) | −39,886 | 243,055 | D | ||
| Open-market sales · 47,195 sh · avg $45.14 · $2,130,382 | |||||||
Loading xslF345X03/doc4.xml…